Remediastinoscopy: Comments and updated results

Lung Cancer

Volumn 42, Issue 3, 2003, Pages 363-364

  Rami Porta, Ramón ^a   Mateu Navarro, Miquel ^a   Serra Mitjans, Mireia ^a   Hernández Rodríguez, Helena ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY ARTERY; REMEDIASTINOSCOPY; SUPERIOR CAVA VEIN;

EID: 0344551767     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.07.006     Document Type: Article

References (8)

1. Van Schil P., Van der Schoot J., Poniewierski J.et al. Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer. 37:2002;281-285.
2. Maas K.W., Schramel F.M.N.H. Repeat mediastinoscopy after neoadjuvant therapy for non-small cell lung cancer. Lung Cancer. 39:2003;347.
3. Cesario A., Margaritora S., Porziella V., Granone P., Trodella L., D'Angelillo R.M. Intrathoracic staging in non-small cell lung cancer: re-do mediastinoscopy revisited. Lung Cancer. 40:2003;227-228.
4. Mateu-Navarro M., Rami-Porta R., Bastus-Piulats R., Cirera-Noguera L., González-Pont G. Remediastinoscopy after induction chemotherapy in non-small cell lung cancer. Ann. Thorac. Surg. 70:2000;391-395.
5. Rami-Porta R., Mateu-Navarro M. Videomediastinoscopy. J. Bronchol. 9:2002;138-144.
6. Betticher D.C., Schmitz S.-F.H., Tösch M.et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small cell lung cancer: a multicenter phase II trial. J. Clin. Oncol. 21:2003;1752-1759.
7. Akhurst T., Downey R.J., Ginsberg M.S.et al. An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann. Thorac. Surg. 73:2002;259-266.
8. Rami-Porta R. Restaging after induction therapy for non-small cell lung cancer. Ann. Thorac. Cardiovasc. Surg. 8:2002;325-327.